ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AMYT Amryt Pharma Plc

143.00
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Amryt Pharma Plc LSE:AMYT London Ordinary Share GB00BKLTQ412 ORD 6P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 143.00 151.00 170.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Amryt Pharma PLC Posting of Annual Report 2017 and Notice of AGM (0827N)

04/05/2018 7:00am

UK Regulatory


Amryt Pharma (LSE:AMYT)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Amryt Pharma Charts.

TIDMAMYT

RNS Number : 0827N

Amryt Pharma PLC

04 May 2018

4 May 2018

AIM: AMYT

ESM: AYP

Amryt Pharma plc

("Amryt" or the "Company")

Posting of Annual Report 2017 and Notice of AGM

Amryt, the biopharmaceutical company focused on rare and orphan diseases, announces that copies of the Annual Report for the year ended 31 December 2017 have today been sent to shareholders along with the Notice of Annual General Meeting ("AGM"). Copies are also available from the Company's website, www.amrytpharma.com.

The AGM will be held at 10am on 5 June 2018 at Holiday Inn London Mayfair, 3 Berkeley Street, Mayfair, London W1J 8NE.

Enquiries:

 
                                       +353 (1) 518 
 Amryt Pharma plc                       0200 
 Joe Wiley, CEO 
  Rory Nealon, CFO/COO 
 
                                       +44 (0) 20 
 Shore Capital                          7408 4090 
 Nomad and Joint Broker 
 Edward Mansfield, Mark 
  Percy, Daniel Bush 
 
                                       +353 (1) 679 
 Davy                                   6363 
 ESM Adviser and Joint 
  Broker 
 John Frain, Anthony Farrell 
                                       +44 (0) 20 
 Stifel                                 7710 7600 
 Joint Broker 
 Jonathan Senior, Ben 
  Maddison 
                                       +44 (0) 20 
 Consilium Strategic Communications     3709 5700 
 Financial PR Adviser 
  Amber Fennell 
  Matthew Neal 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCSSWFIDFASEDI

(END) Dow Jones Newswires

May 04, 2018 02:00 ET (06:00 GMT)

1 Year Amryt Pharma Chart

1 Year Amryt Pharma Chart

1 Month Amryt Pharma Chart

1 Month Amryt Pharma Chart

Your Recent History

Delayed Upgrade Clock